Back to Search
Start Over
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe
- Source :
- Journal of Hepatology, Journal of Hepatology, 2018, 68 (3), pp.402-411. ⟨10.1016/j.jhep.2017.10.010⟩, Journal of hepatology, 68(3), 402-411. Elsevier, Fraser, H, Martin, N, Brummer-Korvenkontio, H, Carrieri, P, Dalgard, O, Dillon, J, Goldberg, D, Hutchinson, S, Jauffret-Roustide, M, Kaberg, M, Matser, A, Matičič, M, Midgard, H, Mravčík, V, Øvrehus, A, Prins, M, Reimer, J, Robaeys, G, Schulte, B, van Santen, D, Zimmermann, R, Vickerman, P & Hickman, M 2018, ' Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe ', Journal of Hepatology, vol. 68, no. 3, pp. 402-411 . https://doi.org/10.1016/j.jhep.2017.10.010, Journal of Hepatology, Elsevier, 2018, 68 (3), pp.402-411. ⟨10.1016/j.jhep.2017.10.010⟩, Fraser, H, Martin, N K, Brummer-Korvenkontio, H, Carrieri, P, Dalgard, O, Dillon, J, Goldberg, D, Hutchinson, S, Jauffret-Roustide, M, Kåberg, M, Matser, A A, Matičič, M, Midgard, H, Mravcik, V, Øvrehus, A, Prins, M, Reimer, J, Robaeys, G, Schulte, B, van Santen, D K, Zimmermann, R, Vickerman, P & Hickman, M 2018, ' Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe ', Journal of Hepatology, vol. 68, no. 3, pp. 402-411 . https://doi.org/10.1016/j.jhep.2017.10.010
- Publication Year :
- 2018
- Publisher :
- HAL CCSD, 2018.
-
Abstract
- Background & Aims: Prevention of hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is critical for eliminating HCV in Europe. We estimated the impact of current and scaled-up HCV treatment with and without scaling up opioid substitution therapy (OST) and needle and syringe programmes (NSPs) across Europe over the next 10 years. Methods: We collected data on PWID HCV treatment rates, PWID prevalence, HCV prevalence, OST, and NSP coverage from 11 European settings. We parameterised an HCV transmission model to setting-specific data that project chronic HCV prevalence and incidence among PWID. Results: At baseline, chronic HCV prevalence varied from 55% (Finland/Sweden), and
- Subjects :
- [SDV]Life Sciences [q-bio]
Hcv transmission
Psychological intervention
Direct-acting antivirals
Hepatitis C
PWID
Opioid substitution therapy
law.invention
0302 clinical medicine
law
Needle-Exchange Programs/methods
Opiate Substitution Treatment/methods
Prevalence
030212 general & internal medicine
Disease Transmission, Infectious/prevention & control
Substance Abuse, Intravenous
Antiviral Agents/therapeutic use
education.field_of_study
Incidence (epidemiology)
Incidence
virus diseases
3. Good health
Europe
Needle-Exchange Programs
[SDV] Life Sciences [q-bio]
Transmission (mechanics)
030211 gastroenterology & hepatology
Needs Assessment
Population
Antiviral Agents
Europe/epidemiology
03 medical and health sciences
Hepatitis C, Chronic/drug therapy
Environmental health
Journal Article
medicine
Disease Transmission, Infectious
Opiate Substitution Treatment
Humans
education
Substance Abuse, Intravenous/complications
Syringe
Hepatology
business.industry
Hepatitis C, Chronic
Models, Theoretical
medicine.disease
Virology
digestive system diseases
Hcv treatment
business
Subjects
Details
- Language :
- English
- ISSN :
- 01688278 and 16000641
- Database :
- OpenAIRE
- Journal :
- Journal of Hepatology, Journal of Hepatology, 2018, 68 (3), pp.402-411. ⟨10.1016/j.jhep.2017.10.010⟩, Journal of hepatology, 68(3), 402-411. Elsevier, Fraser, H, Martin, N, Brummer-Korvenkontio, H, Carrieri, P, Dalgard, O, Dillon, J, Goldberg, D, Hutchinson, S, Jauffret-Roustide, M, Kaberg, M, Matser, A, Matičič, M, Midgard, H, Mravčík, V, Øvrehus, A, Prins, M, Reimer, J, Robaeys, G, Schulte, B, van Santen, D, Zimmermann, R, Vickerman, P & Hickman, M 2018, ' Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe ', Journal of Hepatology, vol. 68, no. 3, pp. 402-411 . https://doi.org/10.1016/j.jhep.2017.10.010, Journal of Hepatology, Elsevier, 2018, 68 (3), pp.402-411. ⟨10.1016/j.jhep.2017.10.010⟩, Fraser, H, Martin, N K, Brummer-Korvenkontio, H, Carrieri, P, Dalgard, O, Dillon, J, Goldberg, D, Hutchinson, S, Jauffret-Roustide, M, Kåberg, M, Matser, A A, Matičič, M, Midgard, H, Mravcik, V, Øvrehus, A, Prins, M, Reimer, J, Robaeys, G, Schulte, B, van Santen, D K, Zimmermann, R, Vickerman, P & Hickman, M 2018, ' Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe ', Journal of Hepatology, vol. 68, no. 3, pp. 402-411 . https://doi.org/10.1016/j.jhep.2017.10.010
- Accession number :
- edsair.doi.dedup.....ea756d10b6f89a0f5b8beaecc8739e57